BioNote바이오노트
377740 · KOSPI · ₩377740 · 바이오노트
₩4,625▲ ₩30 (0.65%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Gross margin | 56.6% | 55.6% | 49.9% | −12.8% | 71.0% |
| Operating margin | 16.2% | 14.1% | 11.9% | −52.2% | 61.6% |
| Net margin | −99.4% | −73.9% | 53.8% | −22.8% | 64.2% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue growth | +6.8% | +15.1% | +14.1% | −81.2% | — |
| Operating income growth | +22.5% | +36.8% | +126.0% | −115.9% | — |
| Net income growth | −43.6% | −258.3% | +369.6% | −106.7% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Return on equity | −8.2% | −5.6% | 3.5% | −1.3% | 19.2% |
| Return on assets | −7.9% | −5.4% | 3.4% | −1.2% | 17.5% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Liabilities to equity | 4.1% | 3.0% | 3.8% | 2.3% | 9.8% |
| Net debt to equity | −4.3% | −0.9% | −6.9% | −9.3% | −42.1% |
| Current ratio | 1,853.5% | 3,101.1% | 1,968.7% | 4,226.3% | 1,666.2% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: BioNote / 바이오노트 / 377740 / KRX:377740
Source: KRX statistical information